Beyond Coronary Artery Disease: Assessing the Microcirculation

Sonal Pruthi1, Emaad Siddiqui1, Nathaniel R Smilowitz2

  • 1Division of Cardiology, Department of Medicine, NYU Langone Health, 550 First Avenue, New York, NY 10016, USA.

Insights

Ischemic heart disease (IHD) affects millions, yet many patients lack blockages in major arteries. Microvascular angina due to coronary microvascular dysfunction (CMD) is a key cause, highlighting the need for better understanding and treatment of CMD.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Internal Medicine

Background:

  • Ischemic heart disease (IHD) impacts over 20 million US adults.
  • Atherosclerosis of epicardial coronary arteries is the traditional cause of IHD.
  • Nearly half of patients with stable angina and IHD lack obstructive epicardial coronary artery disease.

Purpose of the Study:

  • To explore the significance of ischemia with nonobstructive coronary arteries (INOCA).
  • To highlight coronary microvascular dysfunction (CMD) as a common cause of INOCA and microvascular angina.
  • To emphasize the potential of improved understanding and management of CMD for IHD patient outcomes.

Main Methods:

  • Review of current literature on IHD, INOCA, and CMD.
  • Analysis of diagnostic approaches for coronary microvascular dysfunction.
  • Discussion of therapeutic strategies for patients with microvascular angina.

Main Results:

  • Coronary microvascular dysfunction (CMD) is a frequent underlying cause of ischemia in patients without obstructive epicardial coronary artery disease.
  • Microvascular angina is a clinical manifestation of CMD.
  • Current diagnostic and treatment paradigms for CMD are evolving.

Conclusions:

  • CMD is a critical, often overlooked, contributor to ischemic heart disease.
  • Further research into the pathophysiology, diagnosis, and treatment of CMD is essential.
  • Addressing CMD offers a promising avenue to improve clinical outcomes for a significant patient population experiencing IHD.